Search
for
Sort by
Research 61–90 of 645
- Bacillus Calmette-Guerin (BCG) Site Reaction After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination
- SWEET SYNDROME: AN UNUSUAL PRESENTATION OF CHRONIC GRANULOMATOUS DISEASE IN A CHILD
- A Case of Relapsed Leprosy Successfully Treated With Sparfloxacin
- Erythematous cutaneous nodules caused by adulterated cocaine
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Drug-Induced Skin, Nail and Hair Disorders
- A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- 85 Primary cutaneous follicle center lymphoma spans yet unrecognised subtypes including polyclonal reactions
- Permanent Makeup Removal Severe Complication—Case Report and Proposal of the Protocol for Its Management
- Controversy: Synthetic hairs and their role in hair restoration?
- Micropigmentation
- Regulatory, Ethical, and Safety Considerations of Exosome‐Based Therapies in Dermatology
- Design of Nanocrystalline Suspension of Dutasteride for Intramuscular Prolonged Delivery
- Squamous cell carcinoma associated with a history of synthetic hair implantation: Two case reports
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Madarosis: A marker of many Maladies
- Skin manifestations associated with systemic diseases – Part I
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Alopecia areata after mogamulizumab treatment
- Mycobacteriosis in a Pet Ferret (Mustela putorius furo) Caused by Mycobacterium xenopi: A Case Report on Neglected Risk of Zoonotic Transmission
- SEBACEOUS ADENITIS IN AKITA DOG – CASE REPORT
- British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology
- Antihelminthic Drugs
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Lucio Phenomenon: Sequelae of Neglected Leprosy
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- ZALCITABINE
- General Dermatology
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives